Skip to main content
. 2019 Jul 11;42(9):1824–1832. doi: 10.2337/dc18-2254

Figure 1.

Figure 1

Cumulative incidence of diabetes for participants with plasma Sb-PFOA at or below median concentration (≤0.5 ng/mL) or above median Sb-PFOA concentration (>0.5 ng/mL) for the placebo-treated group (A) and the lifestyle intervention group (B).